Pinsent Masons advises Europcar on refinancing

International law firm Pinsent Masons is advising car rental company, Europcar Group UK Limited, on its £500 million asset refinancing.
The deal will see the extension and refinancing of Europcar’s funding arrangements with various lenders, the main purpose of which is to allow Europcar UK to acquire vehicles for the performance of its daily rental business.

More >>

Tags:  Pinsent Masons LLP

Shearman & Sterling Advises on Caixa Econômica Federal’s $1.3 Billion Notes Offering

Shearman & Sterling represented Caixa Econômica Federal, the largest fully government-owned bank in Latin America, in connection with the issuance of $1,300,000,000 4.250% Senior Notes Due 2019 under its $5,000,000,000 Medium-Term Note Program. The notes are listed on the Luxembourg Stock Exchange. BB Securities Ltd., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Banco Bradesco BBI S.A., Banco BTG Pactual S.A.-Cayman Branch, Itau BBA USA Securities, Inc. and J.P. Morgan Securities LLC acted as joint lead managers.

More >>

Tags:  Shearman & Sterling LLP

Walker & Dunlop Provides $278M Fannie Mae Credit Facility

Vinson & Elkins advised Milestone Apartments REIT in connection with Walker & Dunlop, Inc.’s $278 million Fannie Mae Credit Facility. The Facility consisted of a mix of fixed and variable rate notes with staggered maturities collateralized by 20 multifamily properties located in Arizona, Florida, Georgia, Tennessee and Texas.

More >>

Paul Hastings Represents Joint Bookrunners in Essar Steel Minnesota’s $450 Million Senior Secured Notes Offering

Paul Hastings LLP, a leading global law firm, announced that the firm represented joint bookrunners Credit Suisse Securities (USA) LLC, Morgan Stanley & Co. LLC and Jefferies LLC in connection with the offering of $450 million of 11.500% senior secured notes due 2020 by Essar Steel Minnesota LLC, a global integrated iron ore producer. The offering closed into escrow and subject to certain conditions, the net proceeds of the notes, together with certain other financing, will be used to complete the construction of a 7.0 million tonnes per annum fully-integrated pellet production facility in northern Minnesota. More >>

Tags:  Paul Hastings, LLP | New York

Seyfarth Represents D.R. Horton in $210 Million Real Estate Acquisition of Crown Communities

Seyfarth Shaw LLP advised D.R. Horton, the largest U.S. residential homebuilder, in connection with its $210 million real estate acquisition of Crown Communities, the largest residential builder in Atlanta and the 28th largest homebuilder in the country.  The deal involved a sales order backlog of approximately 420 homes sold, 640 homes in inventory and 2,350 lots. D.R. Horton also acquired control of approximately 3,400 lots through option contracts. More >>

Tags:  Seyfarth Shaw LLP

Cahill Represents Initial Purchasers in $625 Million Notes Offering by Kratos

Cahill represented SunTrust Robinson Humphrey as sole book-running manager and the co-managers in connection with the Rule 144A offering of $625,000,000 aggregate principal amount of 7% Senior Secured Notes due 2019 by Kratos Defense & Security Solutions, Inc., a specialized security technology business providing mission critical products, solutions and services for domestic and international customers. Proceeds from the offering were used refinance existing indebtedness. More >>

Tags:  Cahill Gordon & Reindel LLP

Cooley Advises Alder Biopharmaceuticals on Initial Public Offering

Cooley LLP announced today that it advised Alder Biopharmaceuticals, Inc. on its $80 million initial public offering. Alder is a Washington-based clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder is currently developing two lead product candidates: ALD403, an investigational monoclonal antibody for migraine, and Clazakizumab, an investigational monoclonal antibody for rheumatoid arthritis and other autoimmune indications, in collaboration with Bristol-Myers Squibb.  The company now trades on the NASDAQ Global Stock Market under the symbol “ALDR.”

More >>

Tags:  Cooley LLP